Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Dhanuka Laboratories Limited, is an unlisted public company incorporated on 24 February, 1993. It is classified as a public limited company and is located in Chennai, Tamil Nadu. It's authorized share capital is INR 14.50 cr and the total paid-up capital is INR 13.85 cr.
Dhanuka Laboratories Limited's operating revenue range is INR 100 cr - 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has decreased by 68.45% over the previous year. At the same time, it's book networth has decreased by 5.59%.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Rahul Dhanuka
Shareholder
|
00150140 | 26 years |
Director | Mridul Dhanuka
Shareholder
|
00199441 | 20 years |
Managing Director | Manish Dhanuka
Shareholder
|
00238798 | 32 years |
Whole-time Director | Arjun Dhanuka
Shareholder
|
00454689 | 17 years |
Director | Seema Dhanuka
Shareholder
|
00455088 | 29 years |
Director | Mahendra Kumar Dhanuka
Shareholder
|
00628039 | 26 years |
Director | Kunj Sonthalia | 00756382 | 10 years |
Director | Urmila Dhanuka
Shareholder
|
01252045 | 24 years |
Director | Sanjay Bagaria | 08280162 | 7 years |
Kmp | Pramod Kumar Singh | <HIDDEN> | 2 years |
Kmp | . Preeti | <HIDDEN> | 1 years |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Axis Bank Limited
No. of Loans: 1
Total Amount : 85.0 cr
HDFC Bank Limited
No. of Loans: 2
Total Amount : 30.1 cr
Yes Bank Limited
No. of Loans: 1
Total Amount : 18.0 cr
The Hongkong and Shanghai Banking Corporation Limited
No. of Loans: 1
Total Amount : 10.0 cr
Bajaj Finance Limited
No. of Loans: 1
Total Amount : 10.0 cr
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
ORCHID PHARMA LIMITED | Tamil Nadu | 1992 | ₹ 50.7 Cr |
ORCHID BIO-PHARMA LIMITED | Tamil Nadu | 2022 | ₹ 15.0 Cr |
Orchid Pharmaceuticals Inc., and Subsidiaries, USA | United States | - | - |
BexelPharmaceuticals Inc., USA | United States | - | - |
DiakronPharmaceuticals Inc, USA | United States | - | - |
Read more
The incorporation date of DHANUKA LABORATORIES LIMITED is 24 February, 1993
The authorized share capital of DHANUKA LABORATORIES LIMITED is INR ₹ 14.5 Cr.
The paid-up capital of DHANUKA LABORATORIES LIMITED is INR ₹ 13.8 Cr.
The registered address of DHANUKA LABORATORIES LIMITED is LINBUZZ BUSINESS CENTRE, 2910B 14TH MAIN ROAD ANNA NAGAR W EST CHENNAI Tamil Nadu - 600040
The CIN number of DHANUKA LABORATORIES LIMITED is U24100TN1993PLC149053.